The Results of this Study Could Improve Outcomes for Duchenne Muscular Dystrophy
source: pixabay.com

The Results of this Study Could Improve Outcomes for Duchenne Muscular Dystrophy

Last month, the pharmaceutical company Sarepta Therapeutics announced the long awaited results of a study that measured lung function in patients with Duchenne muscular dystrophy (DMD) after they took eteplirsen,…

Continue Reading The Results of this Study Could Improve Outcomes for Duchenne Muscular Dystrophy
These Rare Disease Treatments Just Became a Lot More Affordable for Australians
source: pixabay.com

These Rare Disease Treatments Just Became a Lot More Affordable for Australians

The Australian government has announced that almost that new treatments worth $300 million are being added to the Pharmaceutical Benefits Scheme. This program provides subsidized medical treatments to citizens of…

Continue Reading These Rare Disease Treatments Just Became a Lot More Affordable for Australians
Medical Professionals Are Starting To Debate Clinical Trial Eligibility Standards
source: pixabay.com

Medical Professionals Are Starting To Debate Clinical Trial Eligibility Standards

According to an article from the Chicago Tribune, many medical specialists are coming to the realization that the eligibility criteria for clinical trials should be reassessed. The problem is that…

Continue Reading Medical Professionals Are Starting To Debate Clinical Trial Eligibility Standards
The European Commission Just Approved MVASI, One of The First Biosimilar Cancer Drugs
source: pixabay.com

The European Commission Just Approved MVASI, One of The First Biosimilar Cancer Drugs

According to an article from PRNewswire, the drug MVASI (biosimilar bevacizumab) was just granted marketing authorization by the European Commission. Developed by Amgen and Allergan, this treatment has been approved…

Continue Reading The European Commission Just Approved MVASI, One of The First Biosimilar Cancer Drugs
Anti-Psychotic Drug Could Prolong The Lives of Amyotrophic Lateral Sclerosis Patients
Pexels / Pixabay

Anti-Psychotic Drug Could Prolong The Lives of Amyotrophic Lateral Sclerosis Patients

According an article from CityNews Toronto, an anti-psychotic medication is undergoing clinical trials in the treating of amyotrophic lateral sclerosis. In other studies, the treatment has shown to help slow…

Continue Reading Anti-Psychotic Drug Could Prolong The Lives of Amyotrophic Lateral Sclerosis Patients